| Literature DB >> 32284694 |
Tianlong Wu1, Honghai Cao2, Lei Liu3, Kan Peng4.
Abstract
BACKGROUND: The risk of malignant transformation of enchondromas (EC) toward central chondrosarcoma is increased up to 35%, while the exact etiology of EC is unknown. The purpose of this research was to authenticate gene signatures during EC and reveal their potential mechanisms in occurrence and development of EC.Entities:
Keywords: biomarkers; enchondromas; gene ontology
Year: 2020 PMID: 32284694 PMCID: PMC7137642 DOI: 10.1177/1559325820907536
Source DB: PubMed Journal: Dose Response ISSN: 1559-3258 Impact factor: 2.658
Figure 1.Vocano plot of differentially expressed genes (DEGs). Red: upregulated genes; Green: downregulated genes.
Figure 2.Heat map of TOP100 differentially expressed genes (DEGs). Red: upregulation; Blue: downregulation.
The Top10 Significant Upregulated and Downregulated DEGs Involved in EC.
| Regulated | Row Names (tT) | logFC |
|
|---|---|---|---|
| upregulated | PENK | 6.282102002 | 6.88E-09 |
| FOSB | 4.577903408 | 3.76E-05 | |
| TRIB3 | 3.0873647 | 1.56E-06 | |
| DLK1 | 2.822339106 | 2.532203E-03 | |
| THBS3 | 2.781973194 | 1.71E-06 | |
| DSPG3 | 2.748504195 | 2.167939E-03 | |
| SLC27A2 | 2.7150976 | 7.26E-07 | |
| NELL1 | 2.6088895 | 2.56E-07 | |
| PRSS23 | 2.405676176 | 3.55E-06 | |
| C1orf24 | 2.399071104 | 1.84E-05 | |
| downregulated | ECRG4 | −5.69745338 | 2.76E-06 |
| LOXL4 | −4.377491179 | 9.47E-07 | |
| SERPINA5 | −2.897102353 | 9.32E-07 | |
| DDIT4 | −2.747095868 | 2.392049E-03 | |
| GBP2 | −2.441809126 | 1.82214E-04 | |
| TF | −2.367202109 | 1.06E-05 | |
| ADM | −2.222022278 | 2.072312E-03 | |
| FAM46C | −2.201757972 | 9.41559E-4 | |
| ERRFI1 | −2.197346735 | 7.16472E-4 | |
| MT1G | −2.192670709 | 3.868122E-3 |
Abbreviations: DEG, differentially expressed gene; EC, enchondroma.
Figure 3.Gene ontology (GO) enrichment analysis.
Figure 4.Gene ontology (GO) Chord.
Enriched Pathways of DEGs.
| Term | Count |
| Genes |
|---|---|---|---|
| Ribosome | 10 | 6.22E-05 | RPS28, RPL23, RPL14, RPL7, RPS3A, RPL21, RPLP1, RPS15A, RPL5, RPL7A |
| ECM-receptor interaction | 7 | 8.95E-04 | COL4A2, TNC, COL3A1, THBS1, COL11A2, COL11A1, THBS3 |
| Protein processing in endoplasmic reticulum | 9 | 1.528426E-03 | ATF4, SEC61B, HSPA1A, RPN2, MAN1A1, DDOST, SAR1A, UBE2E2, RBX1 |
| Focal adhesion | 9 | 5.197548E-03 | COL4A2, CAV1, TNC, COL3A1, PDGFD, THBS1, COL11A2, COL11A1, THBS3 |
| PI3K-Akt signaling pathway | 11 | 1.3784745E-02 | COL4A2, ATF4, TNC, COL3A1, CDK6, PDGFD, THBS1, COL11A2, COL11A1, THBS3, DDIT4 |
| Mineral absorption | 4 | 2.1672904E-02 | SLC11A2, TF, FTH1, MT1G |
Abbreviations: DEG, differentially expressed gene; ECM, extracellular matrix.
Figure 5.Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Red: upregulated genes; Green: downregulated genes.
Figure 6.Protein–protein interaction network of differentially expressed genes (DEGs). Circles represent genes, lines represent the interaction of proteins between genes, and the outcomes within the circle represent protein structures. Line color represents protein interactions.
Figure 7.Top 3 modules from the protein–protein interaction network. A, module 1; B, module 2; C, module 3.
Respective Enriched Pathways of Module 1.
| Term | Count |
| Genes |
|---|---|---|---|
| hsa03010: Ribosome | 10 | 7.12E-14 | RPS28, RPL23, RPL14, RPL7, RPS3A, RPL21, RPLP1, RPS15A, RPL5, RPL7A |
| hsa04141: Protein processing in endoplasmic reticulum | 3 | 0.033412617 | SEC61B, RPN2, DDOST |
Respective Enriched Pathways of Module 2.
| Term | Count |
| Genes |
|---|---|---|---|
| hsa04512: ECM-receptor interaction | 3 | 1.57E-04 | COL4A2, COL3A1, COL11A1 |
| hsa04974: Protein digestion and absorption | 3 | 1.60E-04 | COL4A2, COL3A1, COL11A1 |
| hsa05146: Amoebiasis | 3 | 2.33E-04 | COL4A2, COL3A1, COL11A1 |
| hsa04510: Focal adhesion | 3 | 8.85E-04 | COL4A2, COL3A1, COL11A1 |
| hsa04151: PI3K-Akt signaling pathway | 3 | 0.002485904 | COL4A2, COL3A1, COL11A1 |
| hsa04611: Platelet activation | 2 | 0.037275359 | COL3A1, COL11A1 |
Abbreviation: ECM, extracellular matrix.
Respective Enriched Pathways of Module 3.
| Term | Count |
| Genes |
|---|---|---|---|
| hsa04120: Ubiquitin mediated proteolysis | 4 | 7.63E-06 | CBLB, SOCS3, UBE2E2, RBX1 |